Edition:
United States

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

6.79HKD
10:33pm EDT
Change (% chg)

HK$-0.03 (-0.44%)
Prev Close
HK$6.82
Open
HK$6.86
Day's High
HK$6.87
Day's Low
HK$6.70
Volume
3,255,630
Avg. Vol
20,004,857
52-wk High
HK$7.15
52-wk Low
HK$4.69

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical appoints Cheng Cheung Ling as executive director, vice chairlady
Monday, 10 Apr 2017 10:01am EDT 

Sino Biopharmaceutical Ltd <1177.HK> :Cheng Cheung Ling has been appointed as an executive director, vice chairlady of board.  Full Article

Sino Biopharmaceutical FY profit attributable HK$1.91 bln
Monday, 13 Mar 2017 10:52am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: FY profit attributable to equity holders HK$1.91 billion, 7.6% higher . FY revenue HK$ 15.83 billion versus HK$14.55 billion .Company recommended payment of a final dividend of HK1.5 cents per share for year ended 31 December, 2016.  Full Article

Sino Biopharmaceutical nine-month net profit HK$1.56 bln
Friday, 18 Nov 2016 04:28am EST 

Sino Biopharmaceutical Ltd <1177.HK> : Declared payment of third quarterly dividend of HK1.5 cents per share for three months ended 30 september, 2016 . 9-mnth net profit HK$1.56 billion versus HK$1.39 billion . 9-month revenue HK$12.33 billion compared to HK$11.44 billion a year ago . Pharmaceutical industry in particular also must face operating challenges caused by ongoing reform in public hospitals . Profit in pharmaceutical industry may also be affected as a result of quality consistency assessment of generic drugs ."Expects a general positive development trend in pharmaceutical industry regardless of adjustment pressure in coming quarter".  Full Article

Sino biopharmaceutical enters into a facility agreement
Wednesday, 28 Sep 2016 05:11am EDT 

Sino Biopharmaceutical Ltd <1177.HK> : Loan facility in an aggregate principal amount of US$300 million . Company, as borrower, entered into a facility agreement with original lenders . Original lenders have agreed to make available to company a dual tranche three-year term loan facility .Amount borrowed under loan facility will be used by company for refinancing of existing loans owed by company.  Full Article

Sino Biopharmaceutical says there was fire in treatment plant at Lianyungang<1177.HK>
Thursday, 1 Sep 2016 10:26am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: On 27 August 2016, there was a fire in an used waste solvent treatment plant at Lianyungang, PRC . Accident did not extend to production plants and the subsidiary has resumed full production . Expects the incident does not have any material impact on the group's general operation, financial position and cash flows. . There were damages to certain properties and facilities of the subsidiary .  Full Article

Sino Biopharmaceutical HY net profit of hk$1.01 bln versus hk$928.2 mln a year ago<1177.HK>
Friday, 26 Aug 2016 05:01am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: Interim results announcement for the six months ended 30 June, 2016 <1177.HK> . HY net profit of hk$1.01 billion versus hk$928.2 million a year ago . HY revenue was approximately hk$8.04 billion, an increase of approximately 8.0% . Declared payment of a second quarterly dividend of hk1.5 cents per share for three months ended 30 June . Believes the pharmaceutical industry will develop as a whole in a healthier and more standardized manner" .  Full Article

Sino Biopharmaceutical appoints Tse Ping as CEO<1177.HK>
Friday, 29 Jul 2016 04:32am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: Resignation of executive director and change of chief executive officer <1177.HK> . Tse Ping, an executive director of the company, has been appointed as the Chief Executive Officer of the company . Says Xu Xiaoyang tendered his resignation as executive director,and Chief Executive Officer .  Full Article

Sino Biopharmaceutical posts qtrly profit attributable HK$528 million<1177.HK>
Wednesday, 18 May 2016 06:03am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: First quarterly results announcement for the three months ended 31 March, 2016 <1177.HK> . Qtrly profit attributable hk$ 528 million versus hk$400.0 million . Qtrly revenue was approximately hk$4.17 billion, an increase of approximately 11.6% over the same period last year . Declared the payment of a quarterly dividend of hk1.5 cents per share for the three months ended 31 March, 2016 .  Full Article

Sino Biopharmaceutical Ltd declared a quarterly dividend payment
Tuesday, 25 Aug 2015 02:23am EDT 

Sino Biopharmaceutical Ltd:Declared a quarterly dividend payment of HK1.5 cents per share for the second quarter ended 30 June, 2015.Dividend will be paid to shareholders on Friday, 25 September, 2015.  Full Article

Sino Biopharmaceutical Ltd announces change of Chairman
Tuesday, 30 Jun 2015 05:00am EDT 

Sino Biopharmaceutical Ltd:Says that Tse Ping has resigned as the Chairman of the Board and the Chairman of the Executive Board Committee and the Nomination Committee, respectively.Says Miss Tse, Theresa Y Y is appointed as an Executive Director, the chairman of the Board and the chairman of the Executive Board Committee and the Nomination Committee, respectively, of the company.  Full Article

More From Around the Web

BRIEF-Sino Biopharmaceutical appoints Cheng Cheung Ling as executive director, vice chairlady

* Cheng Cheung Ling has been appointed as an executive director, vice chairlady of board Source text for Eikon: Further company coverage: